Landscape Capital Management L.L.C. Purchases 864 Shares of Humana Inc. (NYSE:HUM)

Landscape Capital Management L.L.C. grew its position in Humana Inc. (NYSE:HUM) by 54.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,451 shares of the insurance provider’s stock after buying an additional 864 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in Humana were worth $776,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Swedbank AB grew its holdings in Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after acquiring an additional 3,085 shares in the last quarter. Ontario Teachers Pension Plan Board lifted its position in shares of Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after purchasing an additional 71,910 shares during the period. Heritage Oak Wealth Advisors LLC bought a new position in shares of Humana during the second quarter valued at approximately $3,456,000. Mandatum Life Insurance Co Ltd increased its holdings in Humana by 115.4% during the third quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock valued at $4,434,000 after buying an additional 7,500 shares during the period. Finally, APG Asset Management US Inc. raised its stake in Humana by 3.0% in the second quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock worth $25,274,000 after buying an additional 1,955 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Stock Up 0.8 %

NYSE:HUM opened at $298.11 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The company’s fifty day moving average price is $276.83 and its 200-day moving average price is $330.68. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18. The firm has a market capitalization of $35.90 billion, a P/E ratio of 26.40, a PEG ratio of 2.33 and a beta of 0.52.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, equities research analysts anticipate that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.19%. Humana’s payout ratio is 31.36%.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HUM. Cantor Fitzgerald reiterated a “neutral” rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Stephens reiterated an “equal weight” rating and issued a $250.00 target price on shares of Humana in a research note on Wednesday, October 9th. JPMorgan Chase & Co. increased their price target on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Barclays lifted their price objective on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. Finally, Piper Sandler cut shares of Humana from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $392.00 to $274.00 in a research report on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.